MYH4

Across TCGA pan-cancer cohorts, MYH4 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MYH4 data layer compared with 22 for mass-spec protein and 12 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MYH4 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated MYH4 expression acts as an unfavorable survival marker.

HNSC are the cancer types where MYH4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.956	1.000	.019	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MYH4–HNSC (OS)

Open the HNSC breakdown →